D. Medical Issued U.S. Patent No. 8050729

Palm Beach, FL 11/28/11 (StreetBeat) -- D. Medical Industries Ltd. (Nasdaq:DMED), a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery, announced today that it has been granted U.S. Patent No. 8050729, entitled "Devices For Continuous Measurement of Glucose in Body Fluid."

This patent protects innovative technology that allows for the combination of a minimally invasive Continuous Glucose Monitor and an insulin pump on the same "patch." Amongst other features, the technology enables the use of a single access point to both accurately test for blood glucose levels and deliver insulin.

Hezkiah Tsoory, D. Medical's Chief Operating Officer, commented, "The ability to accurately monitor glucose levels and deliver insulin via a single device employing a common insertion point represents a major breakthrough in the delivery of a safe, convenient and minimally invasive experience for insulin pump users. As we continue to develop our product pipeline for commercialization, it is important that the innovations that will define these future products are well protected. This U.S. patent issuance serves again to strengthen D. Medical's already formidable intellectual property estate."

About D. Medical
D. Medical is a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery. D. Medical has developed durable and semi-disposable insulin pumps, which continuously infuse insulin into a patient's body, using its proprietary spring-based delivery technology. D. Medical believes that its spring-based delivery mechanism is cost-effective compared to the motor and gear train mechanisms that drive competitive insulin pumps and also allows it to incorporate certain advantageous functions and design features in its insulin pumps. D. Medical has also developed an infusion set for insulin pumps and is focusing its research and development efforts on the development of next generation insulin pumps and a device that will combine a continuous glucose monitoring system and an insulin pump on the same patch.

StreetBeat Disclaimer

Distributed by Viestly